−0.050CAD
−300.00 KCAD
250.32 KCAD
5.72 M
About ENTHEON BIOMEDICAL CORP.
Sector
CEO
Timothy Ko
Headquarters
Vancouver
Website
Founded
2010
ISIN
CA29383X2023
FIGI
BBG00KTGG545
Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENBI is 0.100 CAD — it has increased by 100.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange ENTHEON BIOMEDICAL CORP. stocks are traded under the ticker ENBI.
ENBI stock is 50.00% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is ENTHEON BIOMEDICAL CORP. there?
Yes, you can track ENTHEON BIOMEDICAL CORP. financials in yearly and quarterly reports right on TradingView.
ENBI net income for the last quarter is −73.56 K CAD, while the quarter before that showed −94.86 K CAD of net income which accounts for 22.45% change. Track more ENTHEON BIOMEDICAL CORP. financial stats to get the full picture.
No, ENBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENTHEON BIOMEDICAL CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENTHEON BIOMEDICAL CORP. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENTHEON BIOMEDICAL CORP. stock shows the sell signal. See more of ENTHEON BIOMEDICAL CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENTHEON BIOMEDICAL CORP. EBITDA is −311.25 K CAD, and current EBITDA margin is −124.96%. See more stats in ENTHEON BIOMEDICAL CORP. financial statements.